Price $9.16 |
Market Cap
734.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.43
|
P/S
3.0
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
324.5
|
Op. Cash Flow
14.2K
|
FCF
0.0
|
|
Op. Margin
-0.10%
|
Net Margin
-10.30%
|
ROE
-14.70%
|
ROI
1.60%
|
|
ROA
-7.50%
|
EPS Growth
-97.40%
|
Current Ratio
2.1
|
Debt/Equity
59.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Xtant Medical Holdings Inc (XTNT) | $0.65 | - | - | 13.5M | Strong Buy |
| Endo International PLC (ENDP) | $8.72 | - | - | 2.49B | Strong Buy |
| Encision Inc (ECIA) | $0.43 | - | - | 4.4M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.22 | - | - | 31.1M | Strong Buy |
| CV Sciences Inc (CVSI) | $0.23 | - | - | 22.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
